BioEnvelop Technologies

BioEnvelop Technologies was a Canadian biotechnology company specializing in the development and manufacture of edible film technologies for the pharmaceutical and nutraceutical industries. The company's proprietary technology focused on oral dissolvable strips, providing an alternative delivery method for active ingredients that improves bioavailability and patient compliance. Their expertise spanned the entire production process, from formulation development to large-scale commercial manufacturing of thin-film products. In 2016, the company's assets, including its manufacturing equipment and intellectual property, were acquired by IntelGenx Technologies Corp. This acquisition enabled IntelGenx to establish a full-scale manufacturing facility for its VersaFilm drug delivery platform. BioEnvelop's legacy continues through the commercialization of various film-based products now managed under the IntelGenx portfolio.